These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 3514085)

  • 1. Milrinone, a new agent for the treatment of congestive heart failure.
    Hasegawa GR
    Clin Pharm; 1986 Mar; 5(3):201-5. PubMed ID: 3514085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.
    Colucci WS; Wright RF; Braunwald E
    N Engl J Med; 1986 Feb; 314(6):349-58. PubMed ID: 2418353
    [No Abstract]   [Full Text] [Related]  

  • 3. New positive inotropic agents for congestive heart failure.
    N Engl J Med; 1986 Aug; 315(6):396-7. PubMed ID: 3736614
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure.
    Baim DS; McDowell AV; Cherniles J; Monrad ES; Parker JA; Edelson J; Braunwald E; Grossman W
    N Engl J Med; 1983 Sep; 309(13):748-56. PubMed ID: 6888453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of novel inotropic agents in the treatment of heart failure.
    LeJemtel TH; Keren G; Reis D; Sonnenblick EH
    J Cardiovasc Pharmacol; 1986; 8 Suppl 9():S47-54. PubMed ID: 2433542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Milrinone: a positive inotropic vasodilator.
    Colucci WS; Jaski BE; Fifer MA; Wright RF; Braunwald E
    Trans Assoc Am Physicians; 1984; 97():124-33. PubMed ID: 6535335
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics of the bipyridines amrinone and milrinone.
    Edelson J; Stroshane R; Benziger DP; Cody R; Benotti J; Hood WB; Chatterjee K; Luczkowec C; Krebs C; Schwartz R
    Circulation; 1986 Mar; 73(3 Pt 2):III145-52. PubMed ID: 3510771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term intravenous milrinone for severe congestive heart failure: the good, bad, and not so good.
    Varriale P; Ramaprasad S
    Pharmacotherapy; 1997; 17(2):371-4. PubMed ID: 9085331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New inotropic agents in the treatment of refractory congestive heart failure].
    Hertzeanu H; Pines A
    Harefuah; 1988 Mar; 114(6):290-3. PubMed ID: 3286406
    [No Abstract]   [Full Text] [Related]  

  • 10. New positive inotropic drugs in the treatment of congestive heart failure.
    Kennedy GT
    Prog Cardiovasc Nurs; 1987; 2(3):100-4. PubMed ID: 2959954
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical effects of intravenous amrinone in patients with congestive heart failure.
    Goldstein RA
    Circulation; 1986 Mar; 73(3 Pt 2):III191-5. PubMed ID: 3510775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inotropic drugs for treatment of the failing heart.
    Maskin CS; Le Jemtel TH; Sonnenblick EH
    Cardiovasc Clin; 1984; 14(3):1-17. PubMed ID: 6327040
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure.
    DiBianco R; Shabetai R; Kostuk W; Moran J; Schlant RC; Wright R
    N Engl J Med; 1989 Mar; 320(11):677-83. PubMed ID: 2646536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Milrinone for long-term therapy of severe heart failure: clinical experience with special reference to maximal exercise tolerance.
    LeJemtel TH; Gumbardo D; Chadwick B; Rutman HI; Sonnenblick EH
    Circulation; 1986 Mar; 73(3 Pt 2):III213-8. PubMed ID: 3510777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure.
    Tommaso CL
    Am J Med; 1986 Feb; 80(2B):36-9. PubMed ID: 3004210
    [No Abstract]   [Full Text] [Related]  

  • 16. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
    Travill CM; Pugh S; Noble MI
    Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of milrinone on left ventricular performance and myocardial contractility in patients with severe heart failure.
    Sonnenblick EH; Grose R; Strain J; Zelcer AA; LeJemtel TH
    Circulation; 1986 Mar; 73(3 Pt 2):III162-7. PubMed ID: 3510772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle.
    Binah O; Sodowick B; Vulliemoz Y; Danilo P; Rosen M
    Circulation; 1986 Mar; 73(3 Pt 2):III46-51. PubMed ID: 3002663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of the use of milrinone in the treatment of acute crisis in patients with congestive heart failure].
    Gun C; Piegas LS; Bianco AC; Freire RB; Ramos RF; Timerman A
    Arq Bras Cardiol; 1995 Sep; 65(3):255-8. PubMed ID: 8579514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of long-term therapy with milrinone and the effects of milrinone withdrawal.
    Monrad ES; Baim DS; Smith HS; Lanoue AS; Silverman KJ; Gervino EV; Grossman W
    Circulation; 1986 Mar; 73(3 Pt 2):III205-12. PubMed ID: 3510776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.